June 25, 2019


US rejects 12 antibiotic-laced shrimp imports from UAE and Mexico in May



In May, the US refused 12 entry lines of shrimp imports for reasons related to banned antibiotics, the Food and Drug Administration (FDA) said, according to the Southern Shrimp Alliance (SSA).


The number represents 13.6% of the 88 total seafood entry line refusals for last month.


In the five months through May, the FDA refused a total of 44 entry lines of shrimp due to veterinary drug residues. compared with 53 all of last year (and 55 in all of 2017). As shown in the table below, the number of shrimp entry line refusals this year exceeds the annual refusals by the FDA from 2002 to 2006.


The 12 shrimp entry lines refused in May were from two different exporters in Mexico (one entry line) and the United Arab Emirates (11 entry lines).


Meanwhile, the FDA reported that it refused two entry lines of shrimp from Bangladesh and India for the presence of salmonella in April and another entry line of shrimp from Vietnam for salmonella in May.